Shenzhen Weiguang Biological Products Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 137.78 million compared to CNY 138.65 million a year ago. Revenue was CNY 137.78 million compared to CNY 138.65 million a year ago. Net income was CNY 25.33 million compared to CNY 26.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.1117 compared to CNY 0.119 a year ago. Diluted earnings per share from continuing operations was CNY 0.1117 compared to CNY 0.119 a year ago.